ArticleClinical epigenetics2019

Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.

Hilary Snider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.